mediasphere medical logo

MED1570 Web Header 718x180

CME Track - Friday, February 19, 2016 (AM)

Event Overview >>

Non-CME Summit - Friday and Saturday, February 19-20, 2016

Event Overview >>

Non-CME Agenda

Non-CME AGENDA | For CME Agenda Click here >>

Agenda

FRIDAY, FEBRUARY 19, 2016

OPENING SESSION:

"Further, Together: Advancing Cancer Care, Faster":  12:30 – 1:00 am
Keynote Speaker:
Bonnie J. Addario,
Chair, Addario Lung Cancer Foundation

LUNG CANCER PROGRAM DEVELOPMENT TRACK DESCRIPTION

Lung cancer can be a winnable disease. Payers are starting to pay for better patient management. Quality metrics and outcomes are being looked at by providers. And patients are better informed about the choices they have in care. All of this makes for an opportune time to focus on lung cancer as a service line. Join key physicians, nurses, hospitals leaders and advocacy groups as they share best practices on building a high quality, high impact lung cancer program. We all have a role to play. By working together, we may improve lung cancer outcomes and give patients back what matters most: time.

Program Development Track:  1:00 – 5:30 pm

  • Reimbursement Updates 2016
  • Navigating Incidental Nodules
  • Building a Lung Screening Program
  • New Approaches to Manage the Varied Nodule Patient

Break:  3:00 – 3:15 pm

  • A Programmatic Approach – A How to Guide to Comprehensive Lung Program Development
  • Building a Lung Nodule Program – An Administrator’s Perspective
  • Building ENB into your Physician Practice
  • Outreach – Marketing Your Program, Survivorship and Caregiver Support
  • Advocacy Partnerships
  • Panel Discussion (All Presenters)

Reception:  6:30 pm – Brisa Lawn
Dinner:  6:45pm – Brisa Lawn

 

SATURDAY, FEBRUARY 20, 2016

EDUCATION TRACK DESCRIPTION

A fragmented care path. A complex disease. Achieving superior clinical outcomes in the environment can be challenging. That’s why we have to work together. A true multidisciplinary collaboration will provide our greatest opportunity for success. In this half-day education session, the multidisciplinary team will share their knowledge and experience with innovative diagnostic and therapeutic treatment options that can improve outcomes for patients.

Education Track:  8:00 – 11:30 am

  • Case Study Competition
  • ENB with Advanced Imaging
    – CBCT
    – CT
  • Advanced Techniques
    – GenCut Molecular Diagnosis for Personalized Medicine
    – CrossCountry with CBCT

Break:  9:30 – 9:45 am

  • Advanced Techniques - Continue 
    – CrossCountry with REBUS
    – Placement of Markers for SBRT with Fiducial Wizard
    – Markers for Localization (VATS & Robotics)
  • Electromagnetic Navigation Bronchoscopy: Expanding Options in Thoracic Oncology
    – Developing a Procedure for Future Therapy Delivery
    – Role of ENB in the Future of Thoracic Oncology

INNOVATION TRACK DESCRIPTION

Recent tool innovations are improving tissue acquisition for molecular diagnostics so we can practice personalized medicine. But innovations in biopsy methods are pushing the boundaries of tissue requirements for lung cancer diagnosis. And therapeutic options could indicate a paradigm shift in cancer treatment. The future of lung cancer diagnosis and therapy isn’t just promising, it’s clear. Is your team ready? Join us for a stimulating discussion and learn what you and your team can do to prepare.

Innovation Track:  12: 30 – 5:00 pm

  • In vivo Diagnosis of Lung Cancer
    – What roles do in vivo, non-biopsy-based tissue identification and characterization play in the future of lung cancer diagnosis?
  • Next Generation Genomic Methods of Lung Cancer Mutation Identification
    – What roles do tissue – and liquid-based analyses play in the future of lung cancer identification and therapy modification?

Break:  3:00 – 3:15 pm

  • Future Therapeutic Options for Local Treatment of Lung Cancer
    – What roles do local therapies play in the future of lung cancer disease management?

CASE STUDY AWARDS PRESENTATION AND PROGRAM CLOSE:  5:00 – 5:15 pm 

Faculty

10th Annual ENB Summit Faculty

Bonnie J. Addario
Chair, Addario Lung Cancer Foundation (ALCF)

Cristobal G. Alvarado, MD, FACS
Asst Professor of Surgery, Quinnipiac School of Medicine
Hartford Healthcare Medical Group

Carlos Anciano, MD
Thoracic Surgery
East Carolina University
Greenville, NC

Abbie Begnaud
Assistant Professor of Medicine
Pulmonary, Allergy, Critical care & Sleep Medicine
University of Minnesota

Krish Bhadra, MD
Interventional Pulmonology
CHI Memorial

Rabih Bechara, MD, FCCP
Division Director: Pulmonary, Interventional & CCM
Cancer Treatment Centers of America/Southeastern
Professor of Medicine
Georgia Regents University School of Medicine

Mark R. Bowling, MD, FCCP
Assistant Professor of Medicine
East Carolina University School of Medicine and Vidant Health
Director of Interventional Pulmonology and Pulmonary Diagnostic Services
Division Chief of Pulmonary and
Critical Care Medicine
Vice Chair of Internal Medicine for
Clinical Affairs.

Carrie Williams Bullock
Director
Avalere Health, LLC

Joseph Cicenia, MD
Pulmonary Medicine
Cleveland Clinic

Angela Criswell, MA
Medical Outreach Manager
Lung Cancer Alliance
Kentucky LEADS

Taylor B. Duck
Physician Outreach Manager
Vidant Health

Susan Garwood, MD
Interventional Pulmonary
HCA Tristar
Sarah Cannon

Kimberly Gottlieb, APN-BC
Nurse Practitioner
Interventional Pulmonary
The University of Chicago

Colette Hicks (Carter) RN, BSN, CCRN
Thoracic Nurse Navigator
St. John Providence – East Region
Lung Screening/Pulmonary Nodule Program

D. Kyle Hogarth, MD, FCCP
Associate Professor of Medicine
Director of Bronchoscopy
University of Chicago

 

Sandeep Khandhar, MD
Surgical Director of Thoracic Oncology
Falls Church, VA

William Krimsky, MD
Chief, Interventional Pulmonology, MFSHC
Pulmonary and Critical Care Associates of Baltimore
Baltimore, MD

Linda Kuhlman, RN, MSN, NE-BC
Vice President Professional and Clinical Services
Mount Nittany Medical Center

Gregory LeMense, MD
Blount Memorial Hospital
Maryville, TN

Amit Mahajan, MD
Interventional Pulmonologist
CVTSA
Inova Health System

Jennifer Mattingley, MD
Interventional Pulmonologist
Director of Pulmonary Nodule Clinic
Gundersen Health System

Douglas J Minnich, MD
Associate Professor of Surgery
University of Alabama at Birmingham

Mark Onaitis, MD
Thoracic Surgery
Duke University Medical Center
Durham, NC

Michael Pritchett, DO, MPH
Director, Chest Center of the Carolinas
First Health Moore Regional Hospital
Pinehurst Medical Clinic
Pinehurst, NC

Amanda Redig, MD
Medical Oncology
Dana-Farber Cancer Institute
Boston, MA

Tawimas Shaipanich, MD
Respirologist, Clinical Associate Professor
of Medicine, Medical Director Bronchoscopy
Pacific Lung Health Centre
St. Paul’s Hospital
Vancouver, BC

Scott Skibo, MD, FCCP
Director, Interventional Thoracic Oncology for WNC
21st Century Oncology

Robert Suh, MD
Director, Diagnostic Radiology
Ronald Reagan UCLA Medical Center

Eric M. Toloza, MD, PhD, FACS, FCCP
Cardiothoracic Surgeon and Associate Member, Department of Thoracic Oncology
H. Lee Moffitt Cancer Center & Research Institute
Associate Professor of Surgery and Associate Professor of Oncologic Sciences
University of South Florida College of Medicine

Paul Walker, MD, FACP
Chief, Hematology /Oncology
Director Thoracic Oncology
Director Hematology/Oncology Fellowship Program
Brody School of Medicine at East Carolina University

CME Agenda

CME AGENDA | For Non-CME Agenda Click here >>

Agenda

FRIDAY, FEBRUARY 19, 2016

Lung Cancer 2016–
How Far We’ve Come: A Year in Review

CME Educational Program:  8:0011:30 am

Agenda
 
7:30AM – 8:00AM   Registration and Breakfast
8:00AM – 8:35AM   Lung Cancer Update: Where are we now?
Amit Mahajan, MD
8:35AM – 9:10AM   Lung Cancer Screening Update
Angela Criswell, MA
9:10AM – 9:45AM   Update on Diagnostic Alternatives
Ashutosh Sachdeva, MD, MBBS, FCCP
9:45AM – 9:55AM   Break
9:55AM-10:30AM   Molecular Genetics & Immunotherapy Update
Alberto Chiappori, MD
10:30AM-11:30AM   Mock Tumor Board
Moderator:
Jennifer Mattingley, MD
Panelists:
Susan Garwood, MD – Interventional Pulmonology
David Perry, MD - Radiation Oncology
Brandon Larsen, MD– Pathology
Sandeep Khandhar, MD – Thoracic Surgery
Robert Suh, MD – Interventional Radiology
Suman Rao, MD – Medical Oncology
Kimberly Gottlieb, APN-BC –Nurse Navigator

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Target Audience

The educational symposium had been designed to enhance the clinical knowledge of interventional pulmonologists, thoracic surgeons, radiation oncologists, medical oncologists, pathologists, anesthesiologists, and fellows, nurses, advanced practice nurses, physician assistants, and respiratory therapists.

Learning Objectives

At the conclusion of the program, participants will be able to:

  • Discuss the current epidemiology of lung cancer
  • Assess the new guidelines for screening, diagnosing, staging and treatment of lung cancer
  • Assess the latest technologies for lung cancer diagnosis
  • Assess the latest technologies for treatment of lung cancer
  • Advise patients on the options available for radiation therapy for early stage non-small cell cancer of the lung
  • Assess technologies available for added patient comfort, decreased morbidity and radiation exposure
  • Understand cultural differences regarding the diagnosis and treatment of lung cancer
  • Assess the value of biomarkers and molecular therapy in the treatment of lung cancer

Commercial Support

This activity is supported through an educational grant from Medtronic.

Faculty

Lung Cancer 2016
How Far We’ve Come: A Year in Review

*Confirmed faculty

Angela Criswell, MA
Manager, Medical Outreach
Lung Cancer Alliance
Frankfurt, KY

Alberto Chiappori, MD
Senior Member, Dept. of Thoracic Oncology,
Dept. of Tumor Biology
Moffitt Cancer Center
Tampa, FL

Susan Garwood, MD
Interventional Pulmonary
HCA TriStar Division,
Sarah Cannon Research Institute
Nashville, TN

Amit Mahajan, MD
Interventional Pulmonologist
Inova Medical Group
Falls Church, VA

Kimberly Gottlieb, APN-BC
Nurse Practitioner
Section of Pulmonary and Critical Care
The University of Chicago
Chicago, IL

Sandeep Khandhar, MD
Surgical Director of Thoracic Oncology
Inova Thoracic Oncology Program
Falls Church, VA

 

Brandon T. Larsen, MD, PhD
Assistant Professor of Pathology
University of Arizona College of Medicine
Tucson, AZ

Jennifer Mattingley, MD
Interventional Pulmonologist
Director of Pulmonary Nodule Clinic
Gundersen Health System
La Crosse, WI

David Perry, MD
Chief, Radiation Oncology
Medical Director, CyberKnife Radiosurgery Program
Medstar Franklin Square Medical Center
Baltimore, MD

Suman Rao, MD
Medical Oncologist
Medstar Health
Baltimore, MD

Ashutosh Sachdeva, MD, MBBS, FCCP
Assistant Professor of Medicine
Director, Interventional Pulmonology Program
University of Maryland Medical Center
Baltimore, MD

Robert Suh, MD
Professor, Radiological Sciences
David Geffen School of Medicine at UCLA
Los Angeles, CA

Accreditation

Accreditation Statement

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through joint sponsorship of Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the ACCME to provide continuing medical education for Physicians and is an accredited provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Ciné-Med designates this educational activity for a maximum of 2.5 AMA PRA CATEGORY 1 Credit(s).Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 2.5 Contact Hours for Nurses.

Disclosure Policy

MediaSphere Medical and Cine-Med adhere to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All Cine-Med and MediaSphere Medical employees in control of content have indicated that they have no relevant financial relationships to disclose.

Faculty Disclosures will be provided at the time of the meeting within course handouts and at the outset of faculty presentations.

Sponsorship

Further, Together: 10th Annual ENB Summit
The future of lung health, from diagnosis to treatment.

Dear Industry Partner

We would like to invite you to join us at the Further, Together: 10th Annual ENB Summit on
February 19–20, 2016 at Dove Mountain, Marana (Tucson), AZ.

Be among the leaders in lung cancer care, connecting to broaden the dialogue about lung cancer, and to foster excellence via multidisciplinary collaboration throughout the care continuum. We will go further, together: advancing cancer care, faster.

Lung cancer is a complex, challenging and frustrating disease state. However, recent developments have created new opportunity to affect patient outcomes, from diagnostic innovations to changes in screening coverage to increasingly holistic, multidisciplinary approaches.

You are an integral part of a patient’s cancer journey, and we want your point of view as we initiate a truly collaborative effort across the lung cancer care continuum.

The Further, Together: 10th Annual ENB Summit explores ways to establish a world-class lung health program, through the use of innovative technology, partnership and vision that will help set the course for treatment in the years to come.

Through the Further, Together: 10th Annual ENB Summit, you’ll:
• Learn how the right programmatic approach can affect patient outcomes
• Examine future trends as well as existing successful lung care programs that have leveraged innovative diagnostic and therapeutic treatment options
• Hear about recent developments, treatment paradigm shifts and the future of thoracic oncology
• Discover innovations that are driving change in diagnosis and, eventually, treatment of lung cancer

We would like to invite you to be a part of this impactful 2 day conference. You will have the opportunity to represent your company and products as you connect with physicians, administrators and nurses across the lung cancer care continuum.

Options for Industry Participation

Program Sponsor $25,000

  • Company recognition in program brochure
  • Two complimentary program registrations (including lunch & dinner programs)
  • 6” Table top exhibit in prime location
  • Company promotional signage displayed in pre-function area
  • Recognition of Company sponsorship at partnership at lunch event (collateral available)
  • Recognition at Company sponsorship at case study awards ceremony

Exhibitor $10,000

  • Company recognition in program brochure
  • Two complimentary program registrations (including lunch & dinner programs)
  • 6” Table top exhibit in prime location
  • Company promotional signage displayed in pre-function area

Industry Program Participation $5000

  • Two complimentary program registrations (including all lunch & dinner programs)

For more information please contact:

Kjirsten O’Brien
763.210.4013
This email address is being protected from spambots. You need JavaScript enabled to view it.

Hotel

riz-carltonThe hotel room block at the site of the ENB Summit,
the Ritz-Carlton Dove Mountain has been exceeded.

Please contact Lindsay Mazzagatti at
This email address is being protected from spambots. You need JavaScript enabled to view it., or 856-438-5125 ext. 125
for assistance in arranging alternative hotel room accommodations.

 











Event Registration

FURTHER, TOGETHER: 10th Annual enb summit

The future of lung health, from diagnosis to treatment.

Connecting leaders in medicine, technology, patient advocacy and administration to broaden the dialogue about lung cancer, and to foster excellence via collaboration throughout the care continuum.

Through the Further, Together: 10th Annual ENB Summit, you’ll:
• Learn how the right programmatic approach can affect patient outcomes
• Examine future trends as well as existing successful lung care programs that have leveraged innovative diagnostic and therapeutic treatment options
• Hear about recent developments, treatment paradigm shifts, and the future of thoracic oncology
• Discover innovations that are driving change in diagnosis, and, eventually, treatment of lung cancer

And you can get CME credit too for the first half of Day 1.

Group Discounts Apply

A team discount will be offered at a $50.00 discount per participant. (2 or more from the same facility)

Registration

Physician   $450.00
Fellows/Resident   $350.00
Nurse/Administrator/Allied Health   $250.00
Guest of Registered Attendee   $200.00

Register Now

*Upon registering for the CME Summit, you will have the opportunity to select attendance to the complimentary Non-CME Summit during the registration process.

Questions and Inquiries please contact:
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

medtronic-logo